Teosyal RHA® Histology and Intradermal Implantation Evaluation Study
Clinical trial NCT04846530 · UNKNOWN
Trial details
- NCT number
- NCT04846530
- Sponsor
- Revance Therapeutics, Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-20
- Primary completion
- 2021-10-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.